PleoPharma Funding: $54M Raised, Series B (2025)

PleoPharma funding overview

PleoPharma is based in Phoenixville. PleoPharma has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for PleoPharma runs through 2025; nothing later has been disclosed. Investors on record include DynaGrow Capital, MintPharma Capital, SuperVision Partners LLC, Castle Hill Capital Partners, Inc.. 4 distinct backers are named across the disclosed rounds.

PleoPharma at a glance

Total raised: $54M
Latest round: Series B
Latest round date: October 2025
Headquarters: Phoenixville
Notable investors: DynaGrow Capital, MintPharma Capital, SuperVision Partners LLC, Castle Hill Capital Partners, Inc.

Frequently asked about PleoPharma funding

How much has PleoPharma raised?: PleoPharma has raised $54M in total disclosed funding across the rounds on record.
Who has invested in PleoPharma?: DynaGrow Capital, MintPharma Capital, SuperVision Partners LLC, Castle Hill Capital Partners, Inc. are named among the investors backing PleoPharma.
What was the latest PleoPharma funding round?: The most recent disclosed round is a Series B, announced in October 2025.
Where is PleoPharma based?: PleoPharma is based in Phoenixville.
When did PleoPharma last raise?: The last disclosed PleoPharma round closed in October 2025 at Series B.

Round data for PleoPharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Phoenixville and backer lists below.

PleoPharma Funding: $54M Raised, Series B (2025)

PleoPharma funding overview

PleoPharma at a glance

Frequently asked about PleoPharma funding

Companies related to PleoPharma (30)

Browse related funding lists (3)